- Report
- September 2024
- 194 Pages
Global
From €4588EUR$4,950USD£3,854GBP
- Report
- May 2024
- 136 Pages
Global
From €6024EUR$6,499USD£5,060GBP
- Clinical Trials
- August 2024
- 240 Pages
Global
From €2317EUR$2,500USD£1,946GBP
- Report
- June 2024
- 200 Pages
Global
From €7369EUR$7,950USD£6,189GBP
- Report
- March 2024
- 200 Pages
Global
From €3847EUR$4,150USD£3,231GBP
- Report
- March 2024
- 186 Pages
Global
From €3651EUR$3,939USD£3,067GBP
- Report
- June 2024
- 200 Pages
Global
From €7369EUR$7,950USD£6,189GBP
- Report
- June 2024
- 200 Pages
Global
From €7369EUR$7,950USD£6,189GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1854EUR$2,000USD£1,557GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1854EUR$2,000USD£1,557GBP
- Report
- February 2024
- 380 Pages
Global
€4630EUR$4,995USD£3,889GBP
- Report
- July 2024
- 150 Pages
Global
From €5515EUR$5,950USD£4,632GBP
- Clinical Trials
- April 2024
- 390 Pages
Global
From €2317EUR$2,500USD£1,946GBP
- Report
- January 2022
- 60 Pages
Global
From €3661EUR$3,950USD£3,075GBP
- Report
- January 2022
- 60 Pages
Global
From €3661EUR$3,950USD£3,075GBP
- Report
- April 2023
- 114 Pages
Global
From €4403EUR$4,750USD£3,698GBP
- Report
- March 2022
- 120 Pages
Global
From €2317EUR$2,500USD£1,946GBP
- Report
- August 2022
United States
From €1798EUR$1,940USD£1,510GBP
- Report
- August 2022
Global
From €918EUR$990USD£771GBP
- Report
- August 2021
Global
From €3699EUR$3,990USD£3,106GBP
Scleroderma is a chronic autoimmune disorder that affects the skin and other organs. Dermatological drugs are used to treat the symptoms of scleroderma, including skin thickening, joint pain, and fatigue. These drugs can be divided into two categories: immunosuppressants and biologics. Immunosuppressants are used to reduce inflammation and suppress the immune system, while biologics are used to target specific proteins that are involved in the disease process.
The scleroderma drug market is highly competitive, with a number of companies offering treatments for the condition. Some of the major players in the market include Pfizer, Novartis, AbbVie, and Sanofi. These companies offer a range of treatments, including immunosuppressants, biologics, and other drugs. Additionally, there are a number of smaller companies that specialize in scleroderma treatments, such as Galapagos, FibroGen, and Fibrocell. Show Less Read more